[1]
“A juxtaposition of safety outcomes between various doses of sodium-glucose co-transporter inhibitors, in insulin-treated type-1 diabetes mellitus patients: a protocol for systematic review and meta-analysis of randomized controlled trials”, J Ideas Health, vol. 3, no. 2, pp. 167–172, Aug. 2020, doi: 10.47108/jidhealth.Vol3.Iss2.56.